These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24410307)

  • 1. Third and fourth generation fluoroquinolone antibacterials: a systematic review of safety and toxicity profiles.
    Sousa J; Alves G; Fortuna A; Falcão A
    Curr Drug Saf; 2014; 9(2):89-105. PubMed ID: 24410307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety profile of the fluoroquinolones: focus on levofloxacin.
    Liu HH
    Drug Saf; 2010 May; 33(5):353-69. PubMed ID: 20397737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative tolerability of the newer fluoroquinolone antibacterials.
    Ball P; Mandell L; Niki Y; Tillotson G
    Drug Saf; 1999 Nov; 21(5):407-21. PubMed ID: 10554054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial safety: focus on fluoroquinolones.
    Owens RC; Ambrose PG
    Clin Infect Dis; 2005 Jul; 41 Suppl 2():S144-57. PubMed ID: 15942881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events of fluoroquinolones vs. other antimicrobials prescribed in primary care: A systematic review and meta-analysis of randomized controlled trials.
    Tandan M; Cormican M; Vellinga A
    Int J Antimicrob Agents; 2018 Nov; 52(5):529-540. PubMed ID: 29702230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolone toxicity profiles: a review focusing on newer agents.
    Lipsky BA; Baker CA
    Clin Infect Dis; 1999 Feb; 28(2):352-64. PubMed ID: 10064255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety concerns with fluoroquinolones.
    Mehlhorn AJ; Brown DA
    Ann Pharmacother; 2007 Nov; 41(11):1859-66. PubMed ID: 17911203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do fluoroquinolones commonly cause arthropathy in children?
    Forsythe CT; Ernst ME
    CJEM; 2007 Nov; 9(6):459-62. PubMed ID: 18072993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriate use of fluoroquinolones in children.
    Principi N; Esposito S
    Int J Antimicrob Agents; 2015 Apr; 45(4):341-6. PubMed ID: 25726705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico assessment of adverse effects of a large set of 6-fluoroquinolones obtained from a study of tuberculosis chemotherapy.
    Tusar M; Minovski N; Fjodorova N; Novic M
    Curr Drug Saf; 2012 Sep; 7(4):313-20. PubMed ID: 23062244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of Side-Effects of Antibacterial Fluoroquinolones: New Drugs versus Old Drugs, a Step Forward in the Safety Profile?
    Rusu A; Munteanu AC; Arbănași EM; Uivarosi V
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing malaria in tuberculosis patients on fluoroquinolone-containing regimens: assessing the risk of QT prolongation.
    Murphy ME; Singh KP; Laurenzi M; Brown M; Gillespie SH
    Int J Tuberc Lung Dis; 2012 Feb; 16(2):144-9, i-iii. PubMed ID: 22236913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and tolerability of fluoroquinolones.
    Norrby SR; Lietman PS
    Drugs; 1993; 45 Suppl 3():59-64. PubMed ID: 7689453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world safety evaluation of musculoskeletal adverse events associated with Korean pediatric fluoroquinolone use: a nationwide longitudinal retrospective cohort study.
    Kim Y; Paik M; Khan C; Kim YJ; Kim E
    Sci Rep; 2019 Dec; 9(1):20156. PubMed ID: 31882917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration's adverse event reporting system.
    Arabyat RM; Raisch DW; McKoy JM; Bennett CL
    Expert Opin Drug Saf; 2015; 14(11):1653-60. PubMed ID: 26393387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A New Criterion for Fluoroquinolone-Associated Disability Diagnosis: Functional Gastrointestinal Disorders.
    Cannizzaro DN; Naughton LF; Freeman MZ; Martin L; Bennett CL; Bove C
    Medicina (Kaunas); 2021 Dec; 57(12):. PubMed ID: 34946316
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and tolerability of fluoroquinolones.
    Sprandel KA; Rodvold KA
    Clin Cornerstone; 2003; Suppl 3():S29-36. PubMed ID: 14992418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety considerations of fluoroquinolones in the elderly: an update.
    Stahlmann R; Lode H
    Drugs Aging; 2010 Mar; 27(3):193-209. PubMed ID: 20210367
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.